NCT02143466 2026-01-30AZD9291 in Combination With Ascending Doses of Novel TherapeuticsAstraZenecaPhase 1 Active not recruiting344 enrolled
NCT05777603 2026-01-12Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting23 enrolled
NCT03452150 2023-04-25D-0316 First Time in Patients Ascending Dose StudyInventisBio Co., LtdPhase 1 Completed84 enrolled